Star-Studded Mammoth Bio Raises $45 Million for Crispr R&D

(Bloomberg) -- Mammoth Biosciences Inc. has raised another $45 million to push forward on plans to develop tests using the latest in the gene-editing technology known as Crispr.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.